It is worth noting that the individuals with low nAb levels as measured by CoVariant-SCAN may still be protected from COVID-19 via mechanisms not directly related to ACE2-RBD blocking, which would require further investigation that is beyond the scope of this study. This evidence concerns the gene ACE2 and COVID-19.